Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankti D Reid

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|June 4, 2020
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19Garth W Strohbehn, Pankti D Reid, Mark J Ratain
Annals of the Rheumatic Diseases|April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritisAnne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Clinical Pharmacology and Therapeutics|November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaGarth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
JAMA|July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|June 4, 2020
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19Garth W Strohbehn, Pankti D Reid, Mark J Ratain
Annals of the Rheumatic Diseases|April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritisAnne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Clinical Pharmacology and Therapeutics|November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaGarth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
JAMA|July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.
Pageof 1